Bibliografía

7/12/2018

image_pdfimage_print
  1. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317-28.

  2. Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 209;374:903-11.

  3. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis. 1999;179:101-6.

  4. World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age. 2008. (Consultado en marzo de 2018.) Disponible en: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/

  5. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408-16.

  6. World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination. Immunization, Vaccines and Biologicals. 2011;10:477.

  7. Howie SRC, Antonio M, Akisanya A, Sambou S, Hakeem I, Secka O, et al. Re-emergence of Haemophilus influenzae type b (Hib) disease in the Gambia following successful elimination with conjugate Hib vaccine. Vaccine. 2007;25:6305-9.

  8. European Centre for Disease Prevention and Control. Annual epidemiological report for 2015 Haemophilus influenzae. Surveill Rep. 2018;(January):1-9.

  9. Centro Nacional de Epidemiología. Enfermedad invasiva por Haemophilus influenzae en España. Sistema de Información Microbiológica. Años 1993-2008. Bol Epidemiol Sem. 2009;17:73-84.

  10. Pachón I, Muñoz A, Tormo A, Amela C, Martín P, Villota J. Estudio de incidencia de enfermedad invasiva por Haemophilus influenzae en España. Bol Epidemiol Sem. 1998;6:49-52.

  11. Centro Nacional de Epidemiología. CIBER de Epidemiología y Salud Pública. Instituto de Salud Carlos III. Resultados de la vigilancia epidemiológica de las enfermedades transmisibles. Informe Anual 2015. Madrid; 2017.

  12. Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP. Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007-2014. Emerg Infect Dis J. 2017;23:396.

  13. World Health Organization. Haemophilus influenzae type B (Hib) vaccination position paper July 2013. Wkly Epidemiol Rec. 2013;39:413-28.

  14. Ladhani S, Neely F, Heath PT, Nazareth B, Roberts R, Slack MP, et al. Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. J Infect. 2009;58:3-14.

  15. Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-01):1-14.

  16. World Health Organization. Information sheet. Observed rate of vaccine reactions. Haemophilus influenzae type B (Hib) vaccine. Geneva; 2012. (Consultado en marzo de 2018.) Disponible en: http://www.who.int/vaccine_safety/initiative/tools/HiB_Vaccine_rates_information_sheet.pdf

image_pdfimage_print


Subir al menú